Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958763 · ClinicalTrials.gov registry record · Phase 2
Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 219
- Enrollment target
NCT00958763 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 219 participants.
The verdict
NCT00958763, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 219 participants
- Enrollment target
Study Summary
The Alcohol Use Reduction in Methadone Individuals with HCV was designed to compare three different types of programs for methadone maintained men and women to determine which of the three programs is most effective for:1) reducing alcohol consumption; 2) improving knowledge of and attitudes toward the disease of hepatitis and the treatment of hepatitis; 3) improving willingness to seek medical care for hepatitis C; 4) completing the 3 sessions on alcohol use reduction; 5) completing the 3 session Hepatitis A and B vaccine; and 6) determining the number of self-reported 12 step alcohol treatment program sessions attended.
Interventions
- BEHAVIORAL Motivational Interviewing, Single - MIS
- BEHAVIORAL Motivational Interviewing Group
- OTHER Usual Care Group - UCG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00958763
The ClinicalTrials.gov registry entry for NCT00958763 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Motivational Interviewing, Single - MIS is the first listed.
NCT00958763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00958763 about?
NCT00958763 is a clinical study titled "Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV)". The Alcohol Use Reduction in Methadone Individuals with HCV was designed to compare three different types of programs for methadone maintained men and women to determine which of the three programs is most effective for:1) reducing alcohol consumption; 2) improving knowledge of and attitudes toward ...
What is the current status of trial NCT00958763?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 219 participants. The study started on 2006-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00958763?
The interventions under investigation include: Motivational Interviewing, Single - MIS (BEHAVIORAL), Motivational Interviewing Group (BEHAVIORAL), Usual Care Group - UCG (OTHER).
Who is sponsoring clinical trial NCT00958763?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.